0.2772 USD
+0.07 (+31.87%)
At close: Jun 23, 2023
0.23 USD
-0.05 (-17.03%)
After Hours: 6/23/2023, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 43% to ONCS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 5.1. This target is 1739.83% above the current price.
- ONCS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ONCS.
- In the previous month the buy percentage consensus was at a similar level.
- ONCS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-14 | BTIG | Downgrade | Buy -> Neutral |
| 2021-03-08 | BTIG | Initiate | Buy |
OncoSec Medical Incorporated / ONCS FAQ
What is the price target for ONCS stock?
6 analysts have analysed ONCS and the average price target is 5.1 USD. This implies a price increase of 1739.83% is expected in the next year compared to the current price of 0.2772.
What is the consensus rating for ONCS stock?
The consensus rating for OncoSec Medical Incorporated (ONCS) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for OncoSec Medical Incorporated stock?
The number of analysts covering OncoSec Medical Incorporated (ONCS) is 6.